Percutaneous Cholecystostomy as an Alternative to Cholecystectomy in High-Risk Patients with Acute Cholecystitis

作者
Salih Tosun,Oktay Yener,Özgür Ekinci,Aman Gapbarov,Murat Aşık,Tunç Eren,Orhan Alımoğlu
出处
期刊:Albanian journal of trauma and emergency surgery [Albanian Society for Trauma and Emergency Surgery]
卷期号:3 (2): 409-416
标识
DOI:10.32391/ajtes.v3i2.39
摘要

Background: Cholecystectomy is the standard treatment for patients with acute cholecystitis. On the other hand, percutaneous cholecystostomy (PC) is an alternative for patients at high-risk for surgery. The aim of this study was to evaluate the clinical outcomes of PC. Methods: Surgically high-risk patients with acute cholecystits having undergone PC at our institution between January 2014 – January 2017 were evaluated. Data including the indications for PC, route of insertion, technical success, clinical improvement, length of hospital stay, mortality rates, procedure related complications, subsequent admissions and performance of interval cholecystectomy were recorded and analyzed. Results: The study group consisted of 30 patients with a mean age of 75.3 ( range: 49–99) years. The indications for PC were acute calculous cholecystitis in 28 (93.3%) and acalculous cholecystitis in 2 (6.7%) patients. All procedures were performed via the transhepatic route. Twenty-five PCs (84.4%) resulted in clinical improvement within five days. A repeated PC was performed in two (6.7%) patients. Seven (23.3%) patients underwent a subsequent cholecystectomy after 6 weeks. An emergent cholecystectomy was performed in one (3.3%) patient. Five (16.7%) patients died from underlying comorbid diseases, unrelated to the biliary system, during the follow-up. Conclusions: Patients with acute cholecystitis were promptly relieved from their symptoms following PC. There were only minor complications following the procedure and an interval cholecystectomy was necessary in only 23.3% of the patients. PC is a safe alternative to choecystectomy in high-risk patients with acute cholecystitis with satisfactory results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
tqdwxawa完成签到,获得积分10
刚刚
飘逸的语海完成签到 ,获得积分10
1秒前
xishanju完成签到,获得积分10
3秒前
怕黑的凝旋完成签到,获得积分10
3秒前
快乐如之发布了新的文献求助10
4秒前
生生完成签到 ,获得积分10
4秒前
4秒前
金岁岁完成签到,获得积分10
4秒前
江涸完成签到,获得积分10
5秒前
燕子完成签到,获得积分20
5秒前
FelicityZXY完成签到 ,获得积分10
6秒前
菲菲完成签到,获得积分10
6秒前
幸识完成签到 ,获得积分10
6秒前
沉默土豆完成签到 ,获得积分10
6秒前
zj完成签到,获得积分10
7秒前
haheihe完成签到,获得积分10
8秒前
周巍完成签到 ,获得积分10
8秒前
偷喝汽水完成签到,获得积分10
9秒前
RRui完成签到,获得积分10
10秒前
邹yc完成签到,获得积分10
10秒前
研友_VZG7GZ的应助被芥末葱采纳,获得10
11秒前
开放鹭洋完成签到,获得积分10
11秒前
笑然发布了新的文献求助10
11秒前
hdhuang完成签到,获得积分10
11秒前
12秒前
果汁完成签到,获得积分10
13秒前
Monkey_Z完成签到,获得积分10
13秒前
巴拉巴拉完成签到 ,获得积分10
14秒前
华仔的应助被无与伦比采纳,获得10
15秒前
自然而然完成签到,获得积分10
15秒前
MrChew完成签到 ,获得积分10
15秒前
机智的凝琴完成签到 ,获得积分20
15秒前
奶黄包完成签到 ,获得积分10
16秒前
16秒前
师霸完成签到,获得积分10
17秒前
广州东站完成签到,获得积分10
17秒前
17秒前
hhhhhh完成签到 ,获得积分20
17秒前
洪旺旺完成签到 ,获得积分10
17秒前
一字勇完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Campbell's Operative Orthopaedics, E-Book 3000
Les Mantodea De Guyane 2000
Energie-Contracting 1500
内視鏡下経鼻経蝶形骨洞手術術後SIADHに対する予防的水制限の安全性と有効性の検討 1000
Guidelines for fracture-safe and fatigue-reliable design of steel structures 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8014463
求助须知:如何正确求助?哪些是违规求助? 9461052
关于积分的说明 21184078
捐赠科研通 7585781
什么是DOI,文献DOI怎么找? 3384577
关于科研通互助平台的介绍 2517738
邀请新用户注册赠送积分活动 2419797